Vaccine and Clinical Trials

Rubella Vaccines

Submit Abstract Register Now

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated.

• Symptomatic prophylaxis
• Arthropod vectors
• Liver and kidneys function in above diseases
• Possibility of Sexual transmission
• Yellow Fever